M
Min-Han Tan
Researcher at Agency for Science, Technology and Research
Publications - 186
Citations - 10277
Min-Han Tan is an academic researcher from Agency for Science, Technology and Research. The author has contributed to research in topics: Cancer & Renal cell carcinoma. The author has an hindex of 40, co-authored 173 publications receiving 8967 citations. Previous affiliations of Min-Han Tan include Singapore General Hospital & National Center for Charitable Statistics.
Papers
More filters
Patent
Microarray gene expression profiling in subtypes of clear cell renal cell carcinoma
Bin Tean Teh,Min-Han Tan +1 more
TL;DR: A nucleic acid probe or a novel set of such probes in a microarray is provided in this paper, where aggressive and non-aggressive CC-RCC tumor types are characterized by differential expression profiles of genes that hybridize with one or more of these probes.
Journal ArticleDOI
Restoring apoptosis dysregulation using survivin inhibitor in nasopharyngeal cancer
Junli Shi,Soo Yee Tan,Andrea Zhe Ern Lee,Siting Zhang,Swarnalatha Lucky Sasidharan,Benjamin Wong,Min-Han Tan,Chwee Ming Lim,Chwee Ming Lim +8 more
TL;DR: In Epstein‐Barr Virus‐driven nasopharyngeal cancer (NPC), virally induced oncogenes can upregulate survivin, and the therapeutic efficacy of YM‐155 (a survivin inhibitor) in NPC is sought, both in vitro and in vivo models.
Journal ArticleDOI
A unique case of spontaneous regression of metastatic papillary renal cell carcinoma: a case report
Rebecca Lim,Puay Hoon Tan,Christopher Cheng,Thirugnanam Agasthian,Hwei Ling Tan,Bin Tean Teh,Min-Han Tan +6 more
TL;DR: An 82 year old Chinese male who experienced spontaneous regression of histologically-verified metastatic type II papillary renal cell carcinoma in the absence of intervening systemic therapy or surgery is presented.
Journal ArticleDOI
The effect of low serum sodium on treatment outcome to vascular endothelial growth factor (VEGF)-targeted therapy in metastatic renal cell carcinoma: Results from a large international collaboration.
Fabio A.B. Schutz,Wanling Xie,D. Y. Heng,F. Donskov,Lori Wood,U. N. Vaishampayan,Min-Han Tan,Mary J. MacKenzie,Christian K. Kollmannsberger,Toni K. Choueiri +9 more
TL;DR: This is the first large multi-institutional report to show that low serum sodium is independently associated with a worse outcome in mRCC pts treated with VEGF-targeted agents.
Journal ArticleDOI
Papillary renal cell carcinoma with metastatic laparoscopic port site and vaginal involvement: a case report
TL;DR: Laparoscopic port-site metastases are associated with the presence of advanced cancer with multiple sites of metastasis and are more likely to be related to tumor factors rather than operative factors.